ID

33880

Descrição

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Palavras-chave

Versões (1)
  1. 05/01/2019 05/01/2019 -
Titular dos direitos

GlaxoSmithKline

Transferido a

5 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Inglês

Eligibility Checklist

1 Formulários  
  1. StudyEvent: ODM
    1. Eligibility Checklist
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
A male or female between, and including, 18 and 50 years of age at the time of the first vaccination.
Descrição

Gender, Age

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0001779
Written informed consent obtained from the subject.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Free of obvious health problems as established by medical history and clinical examination before entering into the study.
Descrição

Health Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018759
If the subject is female, she must be of non-childbearing, i.e., either surgically sterilised or one year post- menopausal; or, if of childbearing potential, she must be abstinent or have used adequate contraceptive precautions (e.g., intrauterine contraceptive device; oral contraceptives; diaphragm or condom in combination with contraceptive jelly, cream or foam; Norplant® or DepoProvera®) for 30 days prior to vaccination, have a negative pregnancy test and must agree to continue such precautions for two months after completion of the vaccination series.
Descrição

Childbearing Potential, Pregnancy test negative

Tipo de dados

text

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
Exclusion Criteria for Enrollment
Descrição

Exclusion Criteria for Enrollment

Alias
UMLS CUI-1
C0680251
UMLS CUI-2
C1516879
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period.
Descrição

Pharmaceutical Preparations, Vaccines

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0042210
Planned administration/administration of a vaccine not foreseen by the study protocol within 30 days of the first dose of vaccine.
Descrição

Administration of vaccine, Planned

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2368628
UMLS CUI [1,2]
C1301732
Previous vaccination against hepatitis B.
Descrição

Hepatitis B vaccination, Previous

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0474232
UMLS CUI [1,2]
C0205156
History of non-response to previous hepatitis B vaccination.
Descrição

Hepatitis B vaccination, Previous, Absent response to treatment

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0474232
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C0438286
Known exposure to hepatitis B within the previous 6 weeks.
Descrição

Hepatitis B, Exposure to

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019163
UMLS CUI [1,2]
C0332157
History of hepatitis B infection.
Descrição

Hepatitis B, Medical History

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019163
UMLS CUI [1,2]
C0262926
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
Descrição

Immunosuppression, Immunologic Deficiency Syndromes, HIV

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4048329
UMLS CUI [1,2]
C0021051
UMLS CUI [1,3]
C0019682
A family history of congenital or hereditary immunodeficiency.
Descrição

Immunodeficiency congenital, Immunologic Deficiency Syndromes, Hereditary, Family history

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0853602
UMLS CUI [1,2]
C0021051
UMLS CUI [1,3]
C0439660
UMLS CUI [1,4]
C0241889
History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
Descrição

Hypersensitivity, Medical History

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0262926
Acute disease at the time of enrolment. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, at the investigator's discretion)
Descrição

Acute Disease, Enrollment

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0001314
UMLS CUI [1,2]
C1516879
Hepatomegaly, right upper quadrant abdominal pain or tenderness.
Descrição

Hepatomegaly, Right upper quadrant pain, Right upper quadrant abdominal tenderness

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019209
UMLS CUI [1,2]
C0235299
UMLS CUI [1,3]
C0238571
Administration of immunoglobulins and/or any blood products within the three months preceding the first dose of study vaccine or planned administration during the study period.
Descrição

Immunoglobulins, Blood product

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021027
UMLS CUI [1,2]
C0456388
Pregnant or lactating female.
Descrição

Pregnancy, Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
Elimination Criteria During the Study
Descrição

Elimination Criteria During the Study

Alias
UMLS CUI-1
C0680251
UMLS CUI-2
C0347984
UMLS CUI-3
C0008976
Subjects being found to be positive for any hepatitis B marker (anti-HBs, anti-HBc, HBsAg) tested at pre-vaccination.
Descrição

Hepatitis B positive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0856706
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.
Descrição

Pharmaceutical Preparations, Vaccines

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0042210
Administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of vaccine(s) and ending 30 days after.
Descrição

Vaccines, Administration procedure

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C1533734
Administration of immunoglobulins and/or any blood products during the study
Descrição

Immunoglobulins, Blood product

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021027
UMLS CUI [1,2]
C0456388
Female deciding to become pregnant.
Descrição

Pregnancy, Planned

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032992
Contraindications to vaccination
Descrição

Contraindications to vaccination

Alias
UMLS CUI-1
C0042196
UMLS CUI-2
C0522473
Hepatomegaly, right upper quadrant abdominal pain or tenderness.
Descrição

Hepatomegaly, Right upper quadrant pain, Right upper quadrant abdominal tenderness

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019209
UMLS CUI [1,2]
C0235299
UMLS CUI [1,3]
C0238571
Anaphylactic reaction following the administration of vaccine(s).
Descrição

Anaphylaxis, Vaccination

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0002792
UMLS CUI [1,2]
C0042196
Pregnancy.
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
Acute disease at the time of vaccination. (Acute disease is defined as the presence of a moderate or severe illness with or without fever). All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness (at the investigator's discretion)
Descrição

Acute Disease, Vaccination

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0001314
UMLS CUI [1,2]
C0042196
Voltar ao início da página

Similar models

Eligibility Checklist

1 Formulários
  1. StudyEvent: ODM
    1. Eligibility Checklist
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Gender, Age
Item
A male or female between, and including, 18 and 50 years of age at the time of the first vaccination.
boolean
C0079399 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
Informed Consent
Item
Written informed consent obtained from the subject.
boolean
C0021430 (UMLS CUI [1])
Health Status
Item
Free of obvious health problems as established by medical history and clinical examination before entering into the study.
boolean
C0018759 (UMLS CUI [1])
Childbearing Potential, Pregnancy test negative
Item
If the subject is female, she must be of non-childbearing, i.e., either surgically sterilised or one year post- menopausal; or, if of childbearing potential, she must be abstinent or have used adequate contraceptive precautions (e.g., intrauterine contraceptive device; oral contraceptives; diaphragm or condom in combination with contraceptive jelly, cream or foam; Norplant® or DepoProvera®) for 30 days prior to vaccination, have a negative pregnancy test and must agree to continue such precautions for two months after completion of the vaccination series.
text
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Item Group
Exclusion Criteria for Enrollment
C0680251 (UMLS CUI-1)
C1516879 (UMLS CUI-2)
Pharmaceutical Preparations, Vaccines
Item
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period.
boolean
C0013227 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Administration of vaccine, Planned
Item
Planned administration/administration of a vaccine not foreseen by the study protocol within 30 days of the first dose of vaccine.
boolean
C2368628 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Hepatitis B vaccination, Previous
Item
Previous vaccination against hepatitis B.
boolean
C0474232 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Hepatitis B vaccination, Previous, Absent response to treatment
Item
History of non-response to previous hepatitis B vaccination.
boolean
C0474232 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0438286 (UMLS CUI [1,3])
Hepatitis B, Exposure to
Item
Known exposure to hepatitis B within the previous 6 weeks.
boolean
C0019163 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
Hepatitis B, Medical History
Item
History of hepatitis B infection.
boolean
C0019163 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
Immunosuppression, Immunologic Deficiency Syndromes, HIV
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
boolean
C4048329 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
C0019682 (UMLS CUI [1,3])
Immunodeficiency congenital, Immunologic Deficiency Syndromes, Hereditary, Family history
Item
A family history of congenital or hereditary immunodeficiency.
boolean
C0853602 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
C0439660 (UMLS CUI [1,3])
C0241889 (UMLS CUI [1,4])
Hypersensitivity, Medical History
Item
History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
Acute Disease, Enrollment
Item
Acute disease at the time of enrolment. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, at the investigator's discretion)
boolean
C0001314 (UMLS CUI [1,1])
C1516879 (UMLS CUI [1,2])
Hepatomegaly, Right upper quadrant pain, Right upper quadrant abdominal tenderness
Item
Hepatomegaly, right upper quadrant abdominal pain or tenderness.
boolean
C0019209 (UMLS CUI [1,1])
C0235299 (UMLS CUI [1,2])
C0238571 (UMLS CUI [1,3])
Immunoglobulins, Blood product
Item
Administration of immunoglobulins and/or any blood products within the three months preceding the first dose of study vaccine or planned administration during the study period.
boolean
C0021027 (UMLS CUI [1,1])
C0456388 (UMLS CUI [1,2])
Pregnancy, Breast Feeding
Item
Pregnant or lactating female.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
Item Group
Elimination Criteria During the Study
C0680251 (UMLS CUI-1)
C0347984 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
Hepatitis B positive
Item
Subjects being found to be positive for any hepatitis B marker (anti-HBs, anti-HBc, HBsAg) tested at pre-vaccination.
boolean
C0856706 (UMLS CUI [1])
Pharmaceutical Preparations, Vaccines
Item
Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) during the study period.
boolean
C0013227 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Vaccines, Administration procedure
Item
Administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of vaccine(s) and ending 30 days after.
boolean
C0042210 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Immunoglobulins, Blood product
Item
Administration of immunoglobulins and/or any blood products during the study
boolean
C0021027 (UMLS CUI [1,1])
C0456388 (UMLS CUI [1,2])
Pregnancy, Planned
Item
Female deciding to become pregnant.
boolean
C0032992 (UMLS CUI [1])
Item Group
Contraindications to vaccination
C0042196 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
Hepatomegaly, Right upper quadrant pain, Right upper quadrant abdominal tenderness
Item
Hepatomegaly, right upper quadrant abdominal pain or tenderness.
boolean
C0019209 (UMLS CUI [1,1])
C0235299 (UMLS CUI [1,2])
C0238571 (UMLS CUI [1,3])
Anaphylaxis, Vaccination
Item
Anaphylactic reaction following the administration of vaccine(s).
boolean
C0002792 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
Pregnancy
Item
Pregnancy.
boolean
C0032961 (UMLS CUI [1])
Acute Disease, Vaccination
Item
Acute disease at the time of vaccination. (Acute disease is defined as the presence of a moderate or severe illness with or without fever). All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness (at the investigator's discretion)
boolean
C0001314 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial